Get the latest Science News and Discoveries

Breaking the safety barrier: Insilico Medicine nominates ISM1354, the next-generation small molecule GIPR antagonist

None

Related news:

Microplastics can affect the next generation without being passed directly from mother to offspring

Insilico Medicine to present first-in-human data for AI-designed pan-TEAD inhibitor ISM6331 at ESMO 2026

Insilico Medicine strengthens its middle east presence with potential blood cancer treatment, generated by AI, first of its kind in the UAE